Atalanta Therapeutics Funding: $262M Raised, Series B (2025)

Atalanta Therapeutics funding overview

Atalanta Therapeutics is a Biotech company based in Boston. Atalanta Therapeutics has raised $262M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series B announced in January 2025. The round record for Atalanta Therapeutics runs through 2025; nothing later has been disclosed. Investors on record include EQT Life Sciences, Sanofi Ventures, RiverVest Venture Partners, Novartis Venture Fund, abrdn Inc, Pictet Alternative Advisors and 3 others. 9 distinct backers are named across the disclosed rounds.

Atalanta Therapeutics at a glance

Total raised: $262M
Latest round: Series B
Latest round date: January 2025
Industry: Biotech
Headquarters: Boston
Notable investors: EQT Life Sciences, Sanofi Ventures, RiverVest Venture Partners, Novartis Venture Fund, abrdn Inc, Pictet Alternative Advisors, Mirae Asset Financial Group, GHR Foundation

Frequently asked about Atalanta Therapeutics funding

How much has Atalanta Therapeutics raised?: Atalanta Therapeutics has raised $262M in total disclosed funding across the rounds on record.
Who has invested in Atalanta Therapeutics?: EQT Life Sciences, Sanofi Ventures, RiverVest Venture Partners, Novartis Venture Fund, abrdn Inc, Pictet Alternative Advisors are named among the investors backing Atalanta Therapeutics.
What was the latest Atalanta Therapeutics funding round?: The most recent disclosed round is a Series B, announced in January 2025.
Where is Atalanta Therapeutics based?: Atalanta Therapeutics is based in Boston.
What sector does Atalanta Therapeutics operate in?: Atalanta Therapeutics is tracked under Biotech from Boston, with $262M in disclosed funding.
When did Atalanta Therapeutics last raise?: The last disclosed Atalanta Therapeutics round closed in January 2025 at Series B.

Every Atalanta Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare Biotech companies in Boston at a similar stage.

Atalanta Therapeutics Funding: $262M Raised, Series B (2025)

Atalanta Therapeutics funding overview

Atalanta Therapeutics at a glance

Frequently asked about Atalanta Therapeutics funding

Atalanta Therapeutics founders (1)

Companies related to Atalanta Therapeutics (40)

Browse related funding lists (9)